Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 4th July 2013
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Concerns over resistant E.coli superbugs

Public Health England launches new study

New research by Public Health England (PHE) will look at the types of antibiotic-resistant ESBL E. coli found in humans and animals.

Resistant strains of the bacterium are a rising problem, and the affect that resistant strains in animals have on humans is poorly understood.

Enzymes called ESBLs (Extended Spectrum Beta-Lactamases) are produced by these strains, making them resistant to antibiotics.

Funded by the Department of Health, the study will look into the most significant reservoirs of the bacteria, and the risks posed to human health. The findings will help to shape future strategies to address the issue.

"The risks posed to human health by resistant E. coli from non-human reservoirs are not fully understood," said Professor Neil Woodford, PHE. "This study will help to disentangle this complex interrelationship.


"Treatment of infections caused by resistant E. coli can be difficult, which is why we need to understand the risks better."


The research will be carried out in collaboration with the Animal Health and Veterinary Laboratories Agency (AHVLA) and Health Protection Scotland, as well as a number of universities.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.